SELECT LANGUAGE BELOW

Your Stool Might Save Lives, and You Could Earn Money For It.

Your Stool Might Save Lives, and You Could Earn Money For It.

It might sound unappealing, but your poop could actually be crucial for saving lives. While most people flush it away without a second thought, feces are becoming increasingly sought after in medical research. **Stool banks**, which are springing up across the U.S., are gathering and processing human feces to treat serious gut diseases, even offering financial compensation for donors.

This growing field, known as **fecal microbiota transplantation (FMT)**, is emerging as a potential treatment for chronic health issues. It’s surprising, perhaps, but this isn’t just about addressing infections. Researchers are also investigating fecal transplants for conditions like autism, obesity, certain cancers, and so on.

Fecal Transplants: More Than Just Poop

You might be thinking: what’s the fascination with feces? Why the sudden interest from doctors and scientists? Well, it turns out your gut houses a diverse community of microbes that significantly influence your health. These **microbes** support everything from digestion to immune function, and when they fall out of balance, it can lead to various health problems.

According to research from **St. Joseph’s Health Care London**, fecal microbiota transplantation (FMT) involves moving healthy stool from a donor into someone with an unhealthy gut microbiome. The objective is to restore equilibrium in the gut, which can help alleviate infections, inflammation, and other conditions. While FMT is primarily used for treating **recurrent Clostridioides difficile infections**, there is increasing interest in its application for other diseases.

“The concept is to use it for ‘poo’ transplants, also known as fecal microbiota transplantation,” explains Associate **Professor Nadeem O. Kaakoush** from UNSW Sydney. “In this process, stool products from healthy donors are transplanted into another person to enhance their health.”

Not All Poop is Created Equal

Of course, not every stool is suitable for this purpose. Although researchers would love to utilize any available poop, there are **strict requirements for donors**. They need to be healthy and free from various viruses, parasites, antibiotic-resistant bacteria, and more. Even someone who seems perfectly healthy may have stool that isn’t appropriate for medical use. **Dr. Kaakoush** highlights that selecting suitable donors is a meticulous process.

“When we transplant feces, we want to ensure the donor is clear of blood-borne viruses (like HIV or hepatitis). We also check that their stool is free from parasites and harmful bacteria (like **Clostridioides difficile**) and certain antibiotic-resistant strains.”

Additionally, donors must reside near a stool bank since fresh samples are vital for **successful transplants**. Despite the challenges, there is a high demand for quality stool.

Donating Poop Could Pay Off

<pAs the need for fecal donations surges, stool banks are beginning to offer payment for qualified donors. Some organizations, like GoodNature, are reportedly offering up to $1,500 monthly for regular stool donations.

While it might sound like an odd way to earn some money, this practice is becoming more accepted as the medical community recognizes the significance of such donations. As **Dr. Kaakoush** states:

“It’s likely that your donation will aid someone with a recurrent **C. difficile** infection. If not, it can still be used in a clinical trial or study for another vital health issue.”

The **FDA** has already approved two commercial FMT products—**Rebyota** and **Vowst**—both aimed at preventing the recurrence of C. difficile infections. The success rates for these treatments are substantial, with **Rebyota** showing a **70.6% success rate**, compared to **57.5%** with placebo. Meanwhile, **Vowst** has managed to reduce recurrence in high-risk patients to just **12.4%**.

“We’re still quite a ways from replicating the entire gut microbial community in a lab, so for now, we need to depend on live microbial products derived from donated feces as research transitions from the lab to clinical settings,” he concluded.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News